Osmosis Investment Management UK Ltd bought a new stake in shares of AMETEK, Inc. (NYSE:AME – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 8,072 shares of the technology company’s stock, valued at approximately $1,953,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. BlackRock Inc. purchased a new position in shares of AMETEK during the second quarter worth approximately $4,725,928,000. Norges Bank purchased a new stake in shares of AMETEK in the 4th quarter worth approximately $831,372,000. Flossbach Von Storch SE bought a new position in shares of AMETEK during the second quarter valued at approximately $662,352,000. Bank of New York Mellon Corp bought a new position in AMETEK in the second quarter worth approximately $624,725,000. Finally, Wellington Management Group LLP lifted its holdings in AMETEK by 302.9% during the fourth quarter. Wellington Management Group LLP now owns 2,807,664 shares of the technology company’s stock worth $576,441,000 after buying an additional 2,110,818 shares during the period. Hedge funds and other institutional investors own 87.43% of the company’s stock.
Insider Activity at AMETEK
In other news, insider David F. Hermance sold 6,608 shares of the business’s stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $254.00, for a total value of $1,678,432.00. Following the completion of the sale, the insider directly owned 42,509 shares in the company, valued at $10,797,286. The trade was a 13.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.54% of the stock is owned by company insiders.
AMETEK Stock Performance
AMETEK (NYSE:AME – Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The technology company reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.10. AMETEK had a return on equity of 16.93% and a net margin of 20.04%.The business had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $1.95 billion. During the same quarter in the previous year, the firm posted $1.78 EPS. The company’s revenue for the quarter was up 15.0% on a year-over-year basis. AMETEK has set its Q3 2026 guidance at 2.080-2.100 EPS and its FY 2026 guidance at 8.200-8.300 EPS. As a group, analysts predict that AMETEK, Inc. will post 8.32 earnings per share for the current year.
AMETEK Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th will be paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, September 15th. AMETEK’s dividend payout ratio is presently 19.88%.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on the stock. BNP Paribas Exane boosted their target price on shares of AMETEK from $270.00 to $280.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Morgan Stanley lifted their price objective on shares of AMETEK from $235.00 to $245.00 and gave the stock an “equal weight” rating in a research report on Friday, July 10th. Royal Bank Of Canada boosted their price objective on shares of AMETEK from $260.00 to $291.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. KeyCorp raised their target price on shares of AMETEK from $260.00 to $295.00 and gave the company an “overweight” rating in a research note on Wednesday, August 5th. Finally, Mizuho set a $270.00 price target on AMETEK in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $266.80.
Read Our Latest Report on AMETEK
AMETEK Profile
AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.
The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.
See Also
- Five stocks we like better than AMETEK
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME – Free Report).
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.
